Author:
Dahmana Naoual,Mugnier Thibault,Gabriel Doris,Favez Tatiana,Kowalczuk Laura,Behar-Cohen Francine,Gurny Robert,Kalia Yogeshvar N.
Funder
Fondation Ernst et Lucie Schmidheiny
Kommission für Technologie und Innovation
Swiss Commission for Technology and Innovation
Université de Genève
Société Académique de Genève
Reference49 articles.
1. Beneficial effect of spironolactone on androgenic alopecia;Adamopoulos;Clin. Endocrinol. (Oxf),1997
2. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial;Afzali;J. Dermatol. Treat.,2012
3. Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris;Berardesca;Int. J. Tissue React.,1988
4. Epidermal mineralocorticoid receptor plays beneficial and adverse effects in skin and mediates glucocorticoid responses;Boix;J, Invest. Dermatol.,2016
5. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne;Brown;Cochrane Database Syst. Rev.,2009
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献